A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.
Gilead, Cognizant expand deal to expedite digital transformation
The use of GenAI is intended to offer improved transparency about Gilead’s medicines to patients as well as internal staff. Credit: Sundry Photography / Shutterstock.com.